1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶马来酸盐
中文名称 | 1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶马来酸盐 |
---|---|
中文同义词 | 维立韦罗马来酸盐;1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶马来酸盐 |
英文名称 | VICRIVIROC MALEATE |
英文同义词 | Vicriviroc Maleate(SCH 417690);(4,6-diMethylpyriMidin-5-yl)(4-((S)-4-((R)-2-Methoxy-1-(4-(trifluoroMethyl)phenyl)ethyl)-3-Methylpiperazin-1-yl)-4-Methylpiperidin-1-yl)Methanone fuMarate;vicriviroc Maleate salt;1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine (2Z)-2-butenedioate VicrivirocMalate;Vicriviroc maleate 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine (2Z)-2-butenedioate;SCH-D;VICRIVIROC MALEATE;VICRIVIROC MALEATE: SCH-D |
CAS号 | 599179-03-0 |
分子式 | C32H42F3N5O6 |
分子量 | 649.7009896 |
EINECS号 | |
相关类别 | 科研试剂 |
Mol文件 | 599179-03-0.mol |
结构式 |
1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶马来酸盐 性质
储存条件 | Store at -20°C |
---|---|
溶解度 | DMSO:50 mg/mL(76.96 mM;需要超声波)H2O:25 mg/mL(38.48 mM;需要超声波和加热) |
形态 | 粉末 |
CCR5 2.5 nM (Ki) |
HIV-1 (JrFL) 3.3 nM (IC90, in PBMC cells) |
HIV-1 (ADA-M) 2.8 nM (IC90, in PBMC cells) |
HIV-1 (301657) 1.8 nM (IC90, in PBMC cells) |
HIV-1 (JV1083) 4.9 nM (IC90, in PBMC cells) |
HIV-1 (RU 570) 10 nM (IC90, in PBMC cells) |
Vicriviroc maleate (SCH-417690 maleate; SCH-D maleate) is a potent, selective and oral bioavailable inhibitor of CCR5, with a K i of 2.5 nM, and also inhibits HIV-1 in PBMC cells, with IC 90 s of 3.3 (JrFL), 2.8 (ADA-M), 1.8 (301657), 4.9 (JV1083) and 10 nM (RU 570). In addition, Vicriviroc maleate shows a mean IC 50 and IC 90 of 0.45 nM and 4 nM for a panel of HIV isolates, and has weak activity against hERG activity (IC 50 , 5.8 μM). Vicriviroc maleate inhibits chemotactic response to MIP-1α with IC 50 values below 1 nM, and suppresses RANTES-induced signaling with a mean IC 50 of 4.2 ± 1.3 nM. Vicriviroc maleate potently suppresses all the viral isolates tested, with geometric mean EC 50 s of 0.04-2.3 nM and IC 90 s of 0.45-18 nM.
Vicriviroc maleate (SCH-417690 maleate; SCH-D maleate; 10 mg/kg) has good oral availablity in rats and monkeys, with no acute CNS or GI effects in rats.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-17377 | Vicriviroc maleate | 1 mg | 954元 | |
2024/04/30 | HY-17377 | 1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶马来酸盐 Vicriviroc maleate | 599179-03-0 | 5mg | 2100元 |